Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis B-Reference-Cited by-同舟云学术

Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis B

Published:2007 Issue:5 Volume:45 Page:1172-1178
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Yoo Byung Chul,Kim Ju Hyun,Chung Young-Hwa,Lee Kwan Sik,Paik Seung Woon,Ryu Soo Hyung,Han Byung Hoon,Han Joon-Yeol,Byun Kwan Soo,Cho Mong,Lee Heon-Ju,Kim Tae-Hun,Cho Se-Hyun,Park Joong-Won,Um Soon-Ho,Hwang Seong Gyu,Kim Young Soo,Lee Youn-Jae,Chon Chae Yoon,Kim Byung-Ik,Lee Young-Suk,Yang Jin-Mo,Kim Haak Cheoul,Hwang Jae Seok,Choi Sung-Kyu,Kweon Young-Oh,Jeong Sook-Hyang,Lee Myung-Seok,Choi Jong-Young,Kim Dae-Ghon,Kim Yun Soo,Lee Heon Young,Yoo Kwon,Yoo Hee-Won,Lee Hyo-Suk

Publisher

Wiley

Subject

Hepatology

Reference24 articles.

1. Hepatitis B Virus Infection

2. Chronic hepatitis B: Update of recommendations

3. Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus

4. Inhibition of Epstein-Barr virus replication by a novel l-nucleoside, 2′-fluoro-5-methyl-β-l-arabinofuranosyluracil

5. In Vitro Susceptibilities of Wild-Type or Drug-Resistant Hepatitis B Virus to (−)-β- d -2,6-Diaminopurine Dioxolane and 2′-Fluoro-5-Methyl-β- l -Arabinofuranosyluracil

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shedding light on the molecular interaction between the Hepatitis B virus inhibitor, clevudine, and human serum albumin: Thermodynamic, spectroscopic, microscopic, and in silico analyses;Journal of Molecular Liquids;2022-12

2. A randomized phase 1b trial of the active site polymerase inhibitor nucleotide ATI ‐2173 in patients with chronic hepatitis B virus infection;Journal of Viral Hepatitis;2022-10-22

3. Assessing the developing pharmacotherapeutic landscape in hepatitis B treatment: a spotlight on drugs in phase II clinical trials;Expert Opinion on Emerging Drugs;2022-04-03

4. Active site polymerase inhibitor nucleotides (ASPINs): Potential agents for chronic HBV cure regimens;Antiviral Chemistry and Chemotherapy;2022-01

5. Clevudine attenuates bleomycin-induced early pulmonary fibrosis via regulating M2 macrophage polarization;International Immunopharmacology;2021-12